Hematopoietic Stem Cell Transplantation Cannot Overcome the Poor Risk Cytogenetics in Secondary AML

2019 ◽  
Vol 19 ◽  
pp. S205
Author(s):  
Mona Hassanein ◽  
Riad El Fakih ◽  
Shahrukh Hashmi
2017 ◽  
Vol 1 (7) ◽  
pp. 477-485 ◽  
Author(s):  
Jurjen Versluis ◽  
Myriam Labopin ◽  
Annalisa Ruggeri ◽  
Gerard Socie ◽  
Depei Wu ◽  
...  

Key Points The preferred donor for patients with poor-risk AML in CR1 proceeding to alloHSCT include MRD or 10/10 MUD. Alternative donors are 9/10 MUD, UCB grafts, and especially haplo, but sufficient numbers and follow-up to define a hierarchy are lacking.


2020 ◽  
Vol 8 (1) ◽  
pp. 67-78 ◽  
Author(s):  
Anne E. Kazak ◽  
Avi Madan Swain ◽  
Ahna L. H. Pai ◽  
Kimberly Canter ◽  
Olivia Carlson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document